This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Fujifilm Irvine Scientific, Inc., National Health Research Institutes, Fujifilm Biosciences Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Irvine, CA (US) (2019 - 2020)
- Santa Ana, CA (US) (2020 - 2023)
Company Filing History:
4 out of 10 
3 out of 189 
1 out of 1 Years Active: 2019-2026
Title: Innovations in Vaccine Production: The Contributions of Hsiao-Tzu Ni
Introduction: Hsiao-Tzu Ni, an accomplished inventor based in Santa Ana, California, has made significant contributions in the field of biomedical research, particularly in vaccine production. With a portfolio of four patents, Ni's work focuses on advancing cellular technologies that enhance the efficacy and efficiency of vaccine manufacturing processes.
Latest Patents: One of Hsiao-Tzu Ni's latest patents involves the development of Madin-Darby canine kidney (MDCK) suspension cell lines that operate in serum-free, chemically-defined media specifically for vaccine production. This patent discloses an adapted MDCK cell line capable of suspension culture without the use of serum. Furthermore, it outlines a chemically-defined medium for culturing the adapted MDCK cell line, along with methods for both growing the cell line and producing vaccines from it. This innovation holds promise for improving vaccine production methodologies, potentially leading to more efficient vaccination strategies.
Career Highlights: Hsiao-Tzu Ni has had a notable career, working with reputed organizations such as Fujifilm Irvine Scientific, Inc. and the National Health Research Institutes. His experience in these institutions has enabled him to play a pivotal role in the advancement of cellular technologies and vaccine research.
Collaborations: Throughout his career, Ni has collaborated with esteemed colleagues, including Rebecca Susan Gilbert and Jenny Bang. These collaborations have facilitated knowledge exchange and furthered the development of innovative solutions in the biomedical field.
Conclusion: Hsiao-Tzu Ni exemplifies the spirit of innovation within the biomedical community. His inventive work on MDCK suspension cell lines offers valuable contributions to vaccine production, showcasing his commitment to enhancing public health through scientific advancements. As he continues to forge ahead, his impact on the field of vaccine research is sure to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile